Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,301 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
When studios tweak a story to save costs, it isn’t just a movie change—it’s a money lesson. Learn how the princess di...
NVIDIA is signaling a bold push into faster AI inference with a new chip design. This move could reshape cloud comput...
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
A circulating XRPL proposal aims to build a dedicated sidechain for exchange-grade options trading, linking it back t...
As Johnson & Johnson prepares July earnings, investors weigh the real case buying johnson thesis driven by durable in...
Global markets retreated as Iran-related tensions intensified, lifting oil and driving a sharp Dow decline of about 1...
Inflation data and hawkish Fed messaging dominate markets this week as investors weigh mortgage rates and the path of...
A seasoned political strategist warns that without a concrete, consumer-focused economic message, Democrats could str...
A 75-year-old with $1.3M faces a $58,000 RMD that could tax most of his Social Security, illustrating how tax rules c...
Harvard Management Company disclosed a strategic reallocation of its crypto portfolio, trimming Bitcoin ETF exposure ...
Delaware announces a plan to create a new legal form for AI-driven firms—the Autonomous AI Company (AIC)—to be triale...